T A Chowdhury

Summary

Affiliation: Central Middlesex Hospital
Country: UK

Publications

  1. ncbi Subclinical type 1 diabetes
    Tahseen A Chowdhury
    Department of Medicine, Central Middlesex Hospital, London, UK
    J R Soc Med 95:203-4. 2002
  2. ncbi Complications and cardiovascular risk factors in South Asians and Europeans with early-onset type 2 diabetes
    T A Chowdhury
    Department of Medicine, Central Middlesex Hospital, London, UK
    QJM 95:241-6. 2002
  3. ncbi Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled Type 2 diabetes in East London
    H Khan
    Department of Diabetes and Metabolism, Royal London Hospital, London, UK
    Diabet Med 25:1108-11. 2008
  4. ncbi Vasopeptidase inhibitors and their potential role in diabetes
    T A Chowdhury
    Department of Medicine, Central Middlesex Hospital, London, UK
    Diabetes Obes Metab 4:89-95. 2002
  5. ncbi Ethnic differences in control of cardiovascular risk factors in patients with type 2 diabetes attending an Inner London diabetes clinic
    T A Chowdhury
    Barts and The London NHS Trust, Department of Diabetes and Metabolic Medicine, Mile End Diabetes Centre, The Royal London Hospital, London, UK
    Postgrad Med J 82:211-5. 2006
  6. ncbi Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion
    V Moyes
    Department of Allergy, The Royal London Hospital, London, UK
    Diabet Med 23:204-6. 2006
  7. ncbi The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?
    T A Chowdhury
    Department of Medicine, Central Middlesex Hospital, London, UK
    Eye (Lond) 16:689-93. 2002
  8. ncbi Should thyroid function tests be done annually in all patients with diabetes?
    M K Badman
    Queen Elizabeth II Hospital, Welwyn Garden City, London, UK
    Diabet Med 19:7-9. 2002
  9. ncbi Relapsing and remitting insulin requiring diabetes: type 1 or type 2?
    Candy Sze
    Specialist Registrar, Department of Diabetes and Metabolism, The Royal London Hospital, London, UK
    J R Soc Med 99:415-6. 2006
  10. ncbi Diabetes care for south Asian patients: a special case
    Tahseen A Chowdhury
    Department of Diabetes and Metabolism, Barts and the London NHS Trust and School of Medicine and Dentistry, London E1 1BB, UK
    Lancet 371:1728-30. 2008

Collaborators

  • Susan V Gelding
  • Gareth G Lavery
  • H Khan
  • V Moyes
  • Candy Sze
  • Mona Waterhouse
  • Asya Khan
  • M K Badman
  • S S Lasker
  • A Croom
  • Diane Gould
  • Graham Hitman
  • R Driver
  • R Mirakian
  • Claire Wilson
  • Veronica L C White
  • Shawarna S Lasker

Detail Information

Publications18

  1. ncbi Subclinical type 1 diabetes
    Tahseen A Chowdhury
    Department of Medicine, Central Middlesex Hospital, London, UK
    J R Soc Med 95:203-4. 2002
  2. ncbi Complications and cardiovascular risk factors in South Asians and Europeans with early-onset type 2 diabetes
    T A Chowdhury
    Department of Medicine, Central Middlesex Hospital, London, UK
    QJM 95:241-6. 2002
    ..Type 2 diabetes is a major cardiovascular risk factor, and early-onset (<40 years) type 2 diabetes is becoming more common...
  3. ncbi Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled Type 2 diabetes in East London
    H Khan
    Department of Diabetes and Metabolism, Royal London Hospital, London, UK
    Diabet Med 25:1108-11. 2008
    ..To determine the prevalence and reasons for refusal to commence insulin in Bangladeshi patients with Type 2 diabetes...
  4. ncbi Vasopeptidase inhibitors and their potential role in diabetes
    T A Chowdhury
    Department of Medicine, Central Middlesex Hospital, London, UK
    Diabetes Obes Metab 4:89-95. 2002
  5. ncbi Ethnic differences in control of cardiovascular risk factors in patients with type 2 diabetes attending an Inner London diabetes clinic
    T A Chowdhury
    Barts and The London NHS Trust, Department of Diabetes and Metabolic Medicine, Mile End Diabetes Centre, The Royal London Hospital, London, UK
    Postgrad Med J 82:211-5. 2006
    ..South Asians have higher risk of diabetic complications compared with white Europeans. The aim of this study was to compare management of cardiovascular risk factors between Bangladeshis and white Europeans...
  6. ncbi Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion
    V Moyes
    Department of Allergy, The Royal London Hospital, London, UK
    Diabet Med 23:204-6. 2006
    ..3%) on 88 units of lispro per day, with little or no skin or systemic reaction. CONCLUSION: This is the first case report of insulin allergy in Type 2 diabetes being successfully managed by CSII...
  7. ncbi The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?
    T A Chowdhury
    Department of Medicine, Central Middlesex Hospital, London, UK
    Eye (Lond) 16:689-93. 2002
    ..A randomised controlled trial is now required to investigate whether the use of systemic lipid lowering therapy is of benefit in patients with exudative maculopathy, even in the absence of dyslipidaemia...
  8. ncbi Should thyroid function tests be done annually in all patients with diabetes?
    M K Badman
    Queen Elizabeth II Hospital, Welwyn Garden City, London, UK
    Diabet Med 19:7-9. 2002
  9. ncbi Relapsing and remitting insulin requiring diabetes: type 1 or type 2?
    Candy Sze
    Specialist Registrar, Department of Diabetes and Metabolism, The Royal London Hospital, London, UK
    J R Soc Med 99:415-6. 2006
  10. ncbi Diabetes care for south Asian patients: a special case
    Tahseen A Chowdhury
    Department of Diabetes and Metabolism, Barts and the London NHS Trust and School of Medicine and Dentistry, London E1 1BB, UK
    Lancet 371:1728-30. 2008
  11. ncbi Preventing diabetes in south Asians
    Tahseen A Chowdhury
    BMJ 327:1059-60. 2003
  12. ncbi Poor glycaemic control caused by insulin induced lipohypertrophy
    Tahseen A Chowdhury
    Mile End Diabetes Centre, The Royal London Hospital, London E1 4DG
    BMJ 327:383-4. 2003
  13. ncbi Are spouses of patients with type 2 diabetes at increased risk of developing diabetes?
    Asya Khan
    Department of Diabetes and Metabolism, Royal London Hospital, London, UK
    Diabetes Care 26:710-2. 2003
    ..To determine whether spouses of patients with type 2 diabetes have an increased risk of diabetes compared with spouses of subjects with normal glucose tolerance...
  14. ncbi Community diabetes: an East London perspective
    Susan V Gelding
    Newham University Hospital, London, UK
    J R Soc Med 98:96-100. 2005
    ..New approaches cross the primary/secondary care divide and are patient focused. The evolution of diabetes care in the UK is illustrated by service developments in Newham, East London...
  15. ncbi Resolution of insulin-requiring diabetes after cessation of chemotherapy for tuberculosis
    Mona Waterhouse
    Department of Diabetes and Metabolism, The Royal London Hospital, London, UK
    J R Soc Med 98:270-1. 2005
  16. ncbi New drugs for the treatment of type 2 diabetes
    Tahseen A Chowdhury
    Department of Diabetes and Metabolism, The Royal London Hospital, London
    Br J Hosp Med (Lond) 68:178-83. 2007
    ..This article reviews new drugs which are likely to become available for use by people with diabetes over the coming year...
  17. ncbi Tough targets are necessary in effective diabetes care
    Tahseen A Chowdhury
    BMJ 325:775. 2002
  18. ncbi Association studies between the HSD11B2 gene (encoding human 11beta-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathy
    Gareth G Lavery
    Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK
    Eur J Endocrinol 146:553-8. 2002
    ..A microsatellite marker within the HSD11B2 gene associates with salt sensitivity and hypertension--phenotypes characterising diabetic nephropathy. Here, we evaluate the HSD11B2 gene as a susceptibility locus for diabetic nephropathy...